bioAffinity Technologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35%.

Top 25 shareholders own 35.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.8%	Harvey Sandler	1,584,144	US$3.9m	0%	no data
7.3%	Steven Girgenti	840,085	US$2.1m	-9.05%	no data
5.06%	Roby Joyce	583,130	US$1.4m	3.21%	no data
2.85%	Nathan Perlmutter	327,909	US$803.4k	0%	no data
1.75%	Maria Zannes	201,242	US$493.0k	73.1%	no data
0.95%	Mohsin Meghji	109,737	US$268.9k	12.1%	no data
0.65%	Peter Knight	75,375	US$184.7k	48.3%	no data
0.45%	Gary Rubin	51,590	US$126.4k	-35.5%	no data
0.4%	Vivienne Rebel	46,228	US$113.3k	221%	no data
0.4%	Timothy Zannes	46,124	US$113.0k	1,170%	no data
0.35%	CapFinancial Partners, LLC, Asset Management Arm	39,885	US$97.7k	-8.61%	no data
0.32%	Geode Capital Management, LLC	36,769	US$90.1k	276%	no data
0.29%	Michael Edwards	33,737	US$82.7k	0%	no data
0.19%	Two Sigma Investments, LP	21,642	US$53.0k	0%	no data
0.18%	Xavier Reveles	20,339	US$49.8k	462%	no data
0.17%	The Vanguard Group, Inc.	20,000	US$49.0k	0%	no data
0.15%	State Street Global Advisors, Inc.	17,600	US$43.1k	0%	no data
0.11%	Jamie Platt	12,668	US$31.0k	0%	no data
0.11%	Creative Planning, LLC	12,095	US$29.6k	0%	no data
0.043%	IFP Advisors, LLC	5,000	US$12.2k	0%	no data
0.035%	Stuart Diamond	4,081	US$10.0k	-87.4%	no data
0.035%	Robert Anderson	4,081	US$10.0k	-87.4%	no data
0.026%	Tower Research Capital LLC	2,961	US$7.3k	-26.9%	no data
0.00036%	Wells Fargo & Company, Private Banking and Investment Banking Arm	41	US$101.6	7.89%	no data
0.00033%	Qube Research & Technologies Ltd	38	US$93.1	0%	no data